Haemonetics
172 hedge funds and large institutions have $1.69B invested in Haemonetics in 2015 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 78 increasing their positions, 59 reducing their positions, and 27 closing their positions.
32% more repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 59
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
2.23% less ownership
Funds ownership: 104.85% → 102.62% (-2.2%)
5% less funds holding
Funds holding: 181 → 172 (-9)
24% less capital invested
Capital invested by funds: $2.21B → $1.69B (-$525M)
30% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 27
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCIM
Black Creek Investment Management
Toronto,
Ontario, Canada
|
+$14.3M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$13.9M |
| 3 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$12.6M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$12.6M |
| 5 |
Millennium Management
New York
|
+$9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VNIM
Vaughan Nelson Investment Management
Houston,
Texas
|
-$23.4M |
| 2 |
SCM
Snyder Capital Management
San Francisco,
California
|
-$20.2M |
| 3 |
VOYA Investment Management
Atlanta,
Georgia
|
-$18M |
| 4 |
Neuberger Berman Group
New York
|
-$16.3M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$13.1M |
HAE Hedge Fund Activity: Q3 2015 in Review
172 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Haemonetics (HAE) for Q3 2015, worth a combined $1.69B — down 24% from $2.21B a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of HAE and 19 opened new positions — a net loss of 8 holders — while 59 trimmed existing stakes and 78 added.
The largest buyer was Black Creek Investment Management, adding an estimated $14.3M. The largest seller was Vaughan Nelson Investment Management, exiting entirely with an estimated $23.4M sold.
- 172 institutional investors held Haemonetics (HAE) as of Q3 2015, down from 181 in Q2 2015.
- Funds reported $1.69B of Haemonetics stock for Q3 2015, down 24% quarter-over-quarter.
- 19 funds opened new Haemonetics positions in Q3 2015 and 27 closed out, a net change of -8 holders.
- The largest Haemonetics buyer in Q3 2015 was Black Creek Investment Management, an estimated $14.3M added.
- The largest Haemonetics seller in Q3 2015 was Vaughan Nelson Investment Management, an estimated $23.4M sold.
Based on aggregated 13F filings for Q3 2015.